γδ T cells that produce the cytokine IL-17 (Tγδ17 cells) are innate-like mediators of immunity that undergo effector programming in the thymus. While regulators of Tγδ17 specialization restricted to various Vγ subsets are known, a commitment factor essential to all Tγδ17 cells has remained undefined. In this study, we identified the transcription factor c-Maf as a universal regulator of Tγδ17 cell differentiation and maintenance. Maf deficiency caused an absolute lineage block at the immature CD24 + CD45RB lo γδ thymocyte stage, which revealed a critical checkpoint in the acquisition of effector functions. Here, c-Maf enforced Tγδ17 cell identity by promoting chromatin accessibility and expression of key type 17 program genes, notably Rorc and Blk, while antagonizing the transcription factor TCF1, which promotes interferon-γ-producing γδ T cells (Tγδ1 cells). Furthermore, γδ T cell antigen receptor (γδTCR) signal strength tuned c-Maf expression, which indicates that c-Maf is a core node that connects γδTCR signals to Tγδ17 cell transcriptional programming.
I L-17-producing γ δ T cells (Tγ δ 17 cells) provide an immediate source of IL-17 at barrier sites, supporting pro-inflammatory immune function. Thus, Tγ δ 17 cells exert non-redundant functions in bacterial and fungal immunity 1, 2 and the development of autoimmunity 3 . Unlike conventional α β T cells, innate-like γ δ T cells become functionally 'preprogrammed' during ontogeny in the thymus 4 . This generates effector cells, including type 1 γ δ T cells (Tγ δ 1 cells) characterized by expression of the cytokine IFN-γ and the transcription factor T-bet, and type 17 Tγ δ 17 cells defined by expression of IL-17A and the transcription factor RORγ t. γ δ T cell development begins in the fetus and occurs as successive 'waves' characterized by distinct usage of γ -chain variable (Vγ ) regions. In mice, Vγ 3 + dendritic epidermal T cells (DETCs) develop first and migrate to the skin 5 , followed by Vγ 4 + T cells that seed the lung and female reproductive mucosa 6 (Vγ nomenclature as in ref. 7 ). Vγ 2 + and Vγ 1 + γ δ T cells develop in the late fetal stages and throughout life. Tγ δ 17 cell specialization also occurs as a discrete functional wave from embryonic day 16 (E16) to birth 8 , and thus Tγ δ 17 cells are enriched for Vγ 4 and Vγ 2 usage.
Both T cell antigen receptor (TCR)-dependent mechanisms and TCR-independent mechanisms underlie γ δ T cell effector commitment in the thymus. γ δ TCR signal strength plays a role such that strong ligand-induced signals drive adoption of the Tγ δ 1 fate, whereas weaker, potentially ligand-independent signals promote the Tγ δ 17 fate [9] [10] [11] . In addition, thymic stroma-derived signals influence γ δ T cell effector identity. Indeed, the Wnt-activated transcription factor TCF1 promotes Tγ δ 1 cell generation and limits Tγ δ 17 cell generation 12 , whereas Notch-induced transcriptional repressor Hes1 and transforming growth factor-β (TGF-β ) signals are necessary for IL-17 production in γ δ thymocytes 13, 14 . Additional complexity resides in the unique regulatory requirements of select γ δ T cell subsets for effector specification. The transcription factor HEB and downstream targets, the HMG-box transcription factors Sox4 and Sox13, are selectively essential for Tγ δ 17 differentiation of the Vγ 2 + subset of γ δ T cells 12, 15 , while the zinc-finger transcription factor PLZF controls the development of IL-17 + Vγ 4 + γ δ T cells 16 .
A universal commitment factor that drives Rorc gene expression and type 17 programming in all γ δ T cells remains unknown.
The AP-1 transcription factor c-Maf is a pleiotropic regulator of T cell effector programming. c-Maf is essential for activation or repression of key cytokine-encoding loci in CD4 + T cells [17] [18] [19] [20] and invariant natural killer T cells 21 , and for the adoption of specialized effector phenotypes by regulatory T cells 22, 23 . Transcriptomic profiling of γ δ thymocyte subsets identified c-Maf as highly co-expressed with Rorc 24 , suggesting a function for c-Maf in γ δ T cell specialization. Here we identified c-Maf as a universal essential regulator of Tγ δ 17 differentiation, required by all Vγ subsets for the induction and maintenance of Tγ δ 17 cells. Specifically, c-Maf activated the chromatin accessibility and expression of key loci in the type 17 effector program (for example, Rorc, Il17a, and Blk) while antagonizing negative regulators of Tγ δ 17 differentiation, such as TCF1 (Tcf7). Following γ δ selection, the induction and magnitude of c-Maf expression was tuned by the strength of γ δ TCR signaling, implicating c-Maf as a rheostat controlling effector γ δ T cell generation.
Results

c-Maf is specifically expressed in Tγδ17 cells and progenitors.
To explore the role of c-Maf in the Tγ δ 17 lineage, we evaluated the expression of c-Maf within the γ δ T cell compartment. In the inguinal lymph nodes (iLNs), spleen, and small intestine lamina propria (SILP), high expression of c-Maf was restricted to RORγ t + γ δ T cells (Fig. 1a ). RORγ t + γ δ T cells were also uniformly c-Maf hi in the thymus, where a subset of mature Tγ δ 17 cells reside 8 . Conversely, Eomes + , T-bet + , CD27 + , or CD45RB hi (refs 4,11 ) Tγ δ 1 cells lacked high expression of c-Maf (Fig. 1a,b ), suggesting that c-Maf selectively marks Tγ δ 17 cells.
In the fetal thymus (FT), c-Maf protein was restricted to γ δ TCR + thymocytes, with low or no c-Maf detected for the early T cell precursor and CD4 − CD8 − double-negative stage 2 (DN2) and DN3 progenitor cell subsets, or in CD4 + CD8 + double-positive (DP) cells (Fig. 1c) . During fetal ontogeny, c-Maf expression was 
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of CD45RB, which is associated with DETC and Tγ δ 1 development 11, 25 , delineated CD45RB hi RORγ t − and CD45RB lo RORγ t + FT γ δ T cell subsets ( Fig. 1e ). We also detected a CD45RB int γ δ TCR int population that contained precursors for both CD45RB hi Eomes + Tγ δ 1 and CD45RB lo RORγ t + Tγ δ 17 cells when cultured in vitro with OP9-DL1 bone marrow stromal cells ( Supplementary Fig. 1c ). Expression of c-Maf was lowest in CD45RB hi Tγ δ 1 cells, intermediate in CD45RB int cells, and highest in the RORγ t + CD45RB lo Tγ δ 17 subset ( Fig. 1e ). Thus, c-Maf is uniformly upregulated during Tγ δ 17 differentiation. c-Maf expression was also restricted to CD73 − γ δ thymocytes ( Fig. 1f ), which include developing Tγ δ 17 cells 15 , and was sustained in RORγ t + Tγ δ 17 cells that transition to the mature CD24 lo stage ( Fig. 1f ). Although Maf mRNA was reported as being enriched in Vγ 2 + thymocytes 24 , we detected c-Maf hi cells in a proportion of all Vγ subsets examined, especially in Vγ 4-enriched cells (gated Vγ 1 − Vγ 2 − Vγ 3 − ; Supplementary Fig. 1d ), which are predominantly Tγ δ 17 cells 11 . Thus, the correlation between RORγ t expression and c-Maf expression in developmental and adult peripheral γ δ T cell populations suggested a critical function for c-Maf in Tγ δ 17 cells. c-Maf is selectively required in peripheral Tγδ17 cells. We bred mice harboring a Maf conditional allele with mice expressing Cre recombinase from the Il7r locus (Il7r Cre ) to delete Maf in lymphoid cells 26, 27 . Maf fl/fl Il7r Cre mice were indistinguishable from Maf +/+ Il7r Cre controls with respect to thymic proportions of DN progenitor T cells or α β and γ δ T cells ( Supplementary Fig. 2a ). Deletion of Maf ablated the Tγ δ 17 cell population, as indicated by the complete loss of RORγ t + , CCR6 + , or IL-17A + γ δ T cells in the spleen, iLNs, and SILP ( Fig. 2a,b and Supplementary Fig. 2b ). In particular, γ δ T cells in the female reproductive tract (FRT) mucosa and dermal γ δ T cells, which are primarily Tγ δ 17 cells, were absent in Maf fl/fl Il7r Cre mice (Fig. 2b,c ). In ~20% of Maf fl/fl Il7r Cre mice, c-Maf + RORγ t + γ δ T cells with non-deleted Maf fl alleles were detected ( Supplementary  Fig. 2c ) and were excluded from analysis. Of note, the proportions and numbers of IFN-γ + , Eomes + , or T-bet + Tγ δ 1 cells were unaltered in Maf fl/fl Il7r Cre mice ( Fig. 2a,b and Supplementary Fig. 2b ), and γ δ TCR hi type 1-associated skin DETCs remained abundant ( Fig. 2c ), indicating that c-Maf is selectively required for Tγ δ 17 cells. Moreover, other RORγ t + subsets, such as group 3 innate lymphoid cells and CD4 + IL-17-producing helper T cells (T H 17) cells, were generated in Maf fl/fl Il7r Cre mice ( Supplementary Fig. 2d ), highlighting a distinct c-Maf dependence in γ δ T cells for RORγ t induction.
Although the representation of c-Maf + cells varies among Vγ subsets, the proportion of Vγ 1, Vγ 2, and Vγ 1 − Vγ 2 − subsets was unchanged in thymic, splenic or iLN γ δ T cells in Maf fl/fl Il7r Cre versus Maf +/+ Il7r Cre mice ( Supplementary Fig. 2e ). However, at mucosal sites where γ δ subsets are highly composed of RORγ t + Tγ δ 17 cells, such as Vγ 4 + cells in the FRT and Vγ 2 + cells in the SILP, the distribution was significantly altered in Maf fl/fl Il7r Cre mice ( Fig. 2 and Supplementary Fig. 2e ). Thus, non-Tγ δ 17 Vγ 2 + cells were unable to compensate for the absence of RORγ t + Vγ 2 + cells in the SILP, potentially reflecting specialized niches for effector γ δ subsets in the SILP.
To evaluate the functional consequence of Tγ δ 17 cell loss, we challenged Maf +/+ Il7r Cre and Maf fl/fl Il7r Cre mice with cutaneous Candida albicans infection, for which both IL-17A and γ δ T cells are required for resistance 28 . Analysis of infected skin at day 3 showed that Maf fl/fl Il7r Cre mice had a sixfold higher C. albicans burden than that of infected Maf +/+ Il7r Cre mice ( Fig. 2d ), implicating c-Mafdependent Tγ δ 17 cells in controlling cutaneous C. albicans infection. Therefore, c-Maf is essential in the γ δ T cell lineage for type 17-associated phenotype and functions.
c-Maf is required for Tγδ17 cell commitment during ontogeny.
To assess the requirement for c-Maf in Tγ δ 17 cell development, we analyzed thymi from Maf +/+ Il7r Cre and Maf fl/fl Il7r Cre fetuses between E16 and E18. While expression of RORγ t was detected in 40% of Maf +/+ Il7r Cre γ δ TCR + FT cells by E18, Maf fl/fl Il7r Cre γ δ thymocytes failed to induce high-level expression of RORγ t ( Fig. 3a and Supplementary Fig. 2b ). The residual Maf fl/fl Il7r Cre RORγ t lo γ δ thymocytes ( Fig. 3a ) may reflect inefficient Rorc activation or misdirected γ δ TCR-mediated α β lineage differentiation. Indeed, RORγ t expression in Maf fl/fl Il7r Cre γ δ T cells was similar to that of wild-type CD3ε − DN cells ( Fig. 3a) , which are in transition to the DP stage. Notably, production of IL-17A ( Fig. 3b ) and expression of the tyrosine protein kinase Blk (Fig. 3c ), which is selectively required for the development of Tγ δ 17 cells 29 , was abolished in Maf fl/fl Il7r Cre thymocytes compared with Maf +/+ Il7r Cre γ δ thymocytes. The downregulation of TCF1 characteristic of Tγ δ 17 differentiation was also impaired, whereas the downregulation of CD45RB was unaffected ( Fig. 3c) . These results reveal a c-Maf-dependent Tγ δ 17 effector specialization checkpoint at the CD45RB lo stage. Reaggregate thymic organ cultures (RTOCs) reconstituted with a mixture of Maf fl/fl Il7r Cre (CD45.2 + ) and Maf-sufficient (CD45.1 + ) DN2 thymocytes indicated that the c-Maf dependence for Tγ δ 17 diversification was cell intrinsic ( Supplementary Fig. 3a ).
Defects in Tγ δ 17 differentiation result in the selective loss of Vγ 2 + or Vγ 4 + subsets 12, 15, 16 . We observed similar proportions of Vγ 1 + , Vγ 2 + , and Vγ 3 + cells in Maf fl/fl Il7r Cre E17 FT compared with control E17 FT ( Supplementary Fig. 3b ), indicating that Maf deficiency did not affect the fetal Vγ distribution. However, the proportion of total mature CD24 lo γ δ thymocytes in Maf fl/fl Il7r Cre FT was decreased ( Supplementary Fig. 3b ). We focused the analysis on Vγ 3 + and Vγ 4 + thymocytes undergoing maturation before birth ( Supplementary Fig. 3c ). Whereas CD24 downregulation on Tγ δ 1-enriched Vγ 3 + cells was normal in Maf fl/fl Il7r Cre FT, Tγ δ 17-associated Vγ 4 + cells (gated Vγ 1 − Vγ 2 − Vγ 3 − ) were arrested at the immature CD24 hi stage ( Supplementary Fig. 3c ). Thus, c-Maf is required for γ δ thymocytes to adopt the type 17 functional program and progress to the CD24 lo mature stage.
To determine the sufficiency of c-Maf in driving Tγ δ 17 differentiation, fetal liver progenitor cells were differentiated into DN T cell precursors on OP9-DL1 cells and transduced with a c-Maf-expressing or empty retroviral vector, and purified DN3 cells were assessed for Tγ δ 17 development following OP9-DL1 culture. c-Maf overexpression cultures showed a 2.7-fold increase in the proportion of RORγ t + CD45RB lo γ δ T cells relative to empty-virus cultures ( Fig. 3d ). A similar enhancement was observed when c-Maftransduced FT γ δ TCR int CD45RB int γ δ T cell precursors were differentiated in RTOC for 8 days ( Supplementary Fig. 3d ). Whereas empty-vector RTOCs displayed a Tγ δ 1-skewed potential for γ δ TCR int CD45RB int γ δ T cell progenitors by generating mostly CD45RB hi cells, c-Maf overexpression directed the differentiation of mainly RORγ t + CD45RB lo cells ( Supplementary Fig. 3d ). Notably, Tγ δ 17 lineage promotion by c-Maf was dependent on γ δ TCR expression, as c-Maf-transduced Rag1 −/− DN3 cells did not upregulate RORγ t in OP9-DL1 culture, whereas transduction of γ δ TCR chains rescued type 17 differentiation among c-Maf + cells ( Fig. 3e ). Together, these data indicate that c-Maf is an essential commitment factor for Tγ δ 17 cell diversification. Articles NaTuRe IMMuNoLogy viability of these cells ( Fig. 4d and Supplementary Fig. 4d ). Thus, Tγ δ 17 cells require c-Maf to maintain viability and lineage identity, including high expression of RORγ t and Blk.
Maf directly regulates the Rorc locus. Motif analysis identified two Maf recognition elements (MAREs) within a conserved noncoding sequence (CNS) located 10 kb from the Rorc(t) transcription start site (TSS) (CNS+ 10) ( Supplementary Fig. 5 ). Chromatin immunoprecipitation (ChIP) assay of purified CD45RB lo γ δ fetal thymocytes indicated significant binding of c-Maf at CNS+ 10 relative to a negative control region (Neg− 5; Fig. 5a ). Consistent with previous ChIP-seq data 20 , c-Maf bound predominantly 1.5 kb upstream of the Rorc(t) TSS (CNS− 1.5) and to a lesser degree at other CNSs in in vitro-polarized T H 17 cells ( Fig. 5a ), indicating that c-Maf occupied distinct cis regions in the Rorc locus in γ δ T cells compared with T H 17 cells. 
Mean fluorescence intensity (MFI) of RORγ t in E18 FT populations (bottom) of RORγ t + γ δ T cells (CD4
, and DP (CD4 + CD8 + ) cells (n = 5). b, IL-17A production following in vitro stimulation of WT or KO fetal thymocytes gated for E17 γ δ T cells (CD3ε + δ TCR + ; top). Graph displays the proportion of WT and KO E17 or E18 γ δ T cells producing IL-17A (n = 5 biological replicates per group). Data combined from three independent experiments. c, Plots and histograms gated for CD4 − CD8 − CD3ε + γ δ TCR + cells in E18 FT WT and KO. d, Developmental progression of in vitro-derived DN3 thymocytes transduced with an empty (Thy1.1 + ) or a c-Maf expression vector and cultured on OP9-DL1 stroma for 13 days. Plots gated for Thy1.1 + transduced γ δ T cells. e, RORγ t expression following differentiation of c-Maf-or γ δ TCR-transduced Rag1 −/− DN3 thymocytes with OP9-DL1 cells for 13 days (left). Histogram comparing c-Maf-versus empty vector-transduced Rag1 −/− DN3 cultures gated for Thy1.1 + CD4 − CD8 − cells. Numbers in plots indicate percent cells in each quadrant or gated area. All panels are representative of at least three independent experiments. All results represent mean ± s.e.m. **P < 0.01; ***P < 0.001; ****P < 0.0001; NS, not significant (two-tailed unpaired Student's t-test).
Articles
NaTuRe IMMuNoLogy
To test whether CNS+ 10 functions as a c-Maf-dependent Rorc enhancer in γ δ T cells, we cloned CNS+ 10 upstream of a minimal promoter (minP) driving a luciferase reporter and assayed activity in wild-type and Maf fl/fl Il7r Cre CD45RB lo γ δ T cells. CNS+ 10 induced a 13-fold increase in activity over that of minP in wild-type cells that was significantly attenuated in Maf fl/fl Il7r Cre Tγ δ 17 cells ( Fig. 5b) Articles NaTuRe IMMuNoLogy respectively (Fig. 5b ), implicating CNS+ 10 as a c-Maf-dependent enhancer. ChIP assay of the histone acetyltransferase p300, which is associated with tissue-specific enhancers 31 , showed enriched binding at Rorc CNS+ 10 in CD45RB lo γ δ T cells (Fig. 5c ), but not T H 17 cells (Fig. 5a ). p300 binding at CNS+ 10 was reduced in E18 Maf fl/fl Il7r Cre CD45RB lo γ δ T cells compared with Maf +/+ Il7r Cre FT (Fig. 5c ). Accordingly, H3K27 acetylation, a product of p300 activity and a marker of active enhancers, was also reduced in Maf fl/fl Il7r Cre CD45RB lo γ δ T cells at CNS+ 10 and at the Rorc(t) promoter ( Fig. 5c ). Thus, c-Maf was required for establishing an active regulatory status at the Rorc locus in γ δ T cells.
To further explore Rorc regulation, we evaluated CNS+ 10 for conserved binding elements and identified consensus sites for TCF1 and RORγ t (ROR response element (RORE)) ( Supplementary  Fig. 5 ). ChIP analysis detected enrichment of RORγ t at Rorc CNS+ 10 in CD45RB lo γ δ T cells ( Fig. 5d ), suggesting that RORγ t can maintain its own expression. Conversely, TCF1 negatively regulates Rorc 12 . Notably, TCF1 also bound CNS+ 10 in CD45RB lo Articles NaTuRe IMMuNoLogy γ δ T cells, and occupancy was elevated in Maf fl/fl Il7r Cre compared with Maf +/+ Il7r Cre (Fig. 5e ), indicating that c-Maf limits binding of TCF1 to Rorc. This effect was specific, as a similar binding enhancement was not observed at Lef1 (CNS− 4 kb, Fig. 5e ). Moreover, the MARE and TCF1 consensus sites in CNS+ 10 were in close proximity ( Supplementary Fig. 5 ), and mutation of the TCF1 site enhanced luciferase reporter activity in CD45RB lo γ δ T cells compared with wild-type CNS+ 10 (Fig. 5b) . These results suggest that c-Maf can regulate Rorc expression both by supporting activating locus modifications and, possibly, by counteracting the accessibility of TCF1, a negative regulator of type 17 differentiation. Supplementary  Fig. 6a ). Of the significantly differential genes, 70% were downregulated in Maf fl/fl Il7r Cre compared with Maf +/+ Il7r Cre . The expression of the core Tγ δ 17 regulators Rorc and Blk was severely diminished (Fig. 6a ), while expression of other T H 17 cell-associated signature genes, including Il17a, Il17f, Il23r, Il1r1, and Ccr6, was completely abolished in Maf fl/fl Il7r Cre γ δ thymocytes ( Supplementary Fig. 6b ). Gene set enrichment analysis indicated that the most highly downregulated genes were significantly enriched in top-ranking T H 17 cell network target genes 20 ( Supplementary Fig. 6c,d) . Thus, c-Maf is a dominant activator of the type 17 program in γ δ T cells.
Aside from Rorc, the expression of genes encoding other positive regulators of Tγ δ 17 cells, namely, Sox4 (ref. 12 ), Sox13 (ref. 12 ), Tcf12 (ref. 15 ), Hes1 (ref. 13 ), Relb (ref. 32 ), Bcl11b (ref. 33 ), and Zbtb16 (ref. 16 ), was not significantly altered in Maf fl/fl Il7r Cre CD25 − CD27 − γ δ thymocytes (Fig. 6b ). Short hairpin RNA-mediated knockdown of Sox13 in fetal liver progenitors prevented c-Maf protein upregulation at the CD45RB lo stage in OP9-DL1 culture, although Maf transcripts were unaltered ( Supplementary Fig. 6e ), suggesting indirect regulation of c-Maf downstream of Sox13. Unlike positive regulators, expression of genes encoding Tγ δ 17 cell negative regulators, Lef1 12 and Tcf7, was significantly elevated in Maf fl/fl Il7r Cre cells (Fig. 6b) , indicating that c-Maf restricts activators of the Tγ δ 1 program. This antagonism supports a role for c-Maf as a Tγ δ 17 commitment factor. c-Maf and RORγt collaborate in Tγδ17 programming. To determine the mechanism of c-Maf-mediated gene regulation during Tγ δ 17 lineage commitment, we used assay for transposase-accessible chromatin using sequencing (ATAC-seq) to evaluate changes in chromatin accessibility in immature CD24 + CD45RB lo γ δ thymocytes from Maf fl/fl Il7r Cre versus Maf +/+ Il7r Cre E18 FT. Consistent with a discrete role for c-Maf in effector programming, only 4% of ATAC regions were differentially accessible (DA) in Maf fl/fl Il7r Cre (Fig. 6c ), most displaying reduced accessibility. This included Rorc, Blk, Il17a, Il17f, Il1r1, Il23r, and Ccr6 (Fig. 6c) . Specifically, we observed significantly diminished chromatin accessibility in the promoter, CNS+ 10 enhancer, and CNS− 1.5 of Rorc(t) and in the MARE-associated CNS of Il17a and Blk in absence of c-Maf (Fig. 6d) . Moreover, 40% of the loci differentially expressed in Maf fl/fl Il7r Cre γ δ thymocytes harbored at least 1 DA region within 10 kb of the TSS (versus 8.5% of non-dependent loci, P value = 8 × 10 −21 Fisher's exact test), suggesting that c-Maf-dependent changes in chromatin accessibility contribute to gene expression at a substantial portion of loci associated with Tγ δ 17 effector acquisition.
We next explored whether c-Maf directly regulates accessibility. De novo motif analysis identified consensus sites for RORγ t and Maf as the top two most significantly enriched motifs among c-Maf-dependent DA regions in immature Tγ δ 17 cells ( Fig. 6c and Supplementary Fig. 6f ). Notably, although MAREs were present in a larger proportion of DA regions than was RORE, the RORE motif was significantly more enriched in DA regions than in non-DA regions ( Supplementary Fig. 6g ). Thus, a substantial fraction of potential RORγ t binding sites in active genomic regions were differentially accessible in the absence of c-Maf. In addition, RORE-containing regions showed the greatest change in chromatin accessibility among c-Maf-dependent DA peaks ( Supplementary  Fig. 6h ). Thus, c-Maf regulated chromatin accessibility during Tγ δ 17 commitment, with a potential dominant contribution of its direct target RORγ t.
To evaluate whether c-Maf-dependent Tγ δ 17 programming was mediated by RORγ t, we performed differential expression analysis for CD25 − CD27 − γ δ thymocytes from Rorc(t) +/+ versus RORγ t-deficient Rorc(t) GFP/GFP E18 FT (where 'GFP' is green fluorescent protein) ( Supplementary Fig. 6i ). Comparing RORγ t-and c-Mafdependent transcriptomes revealed a high correlation in the regulation of gene expression, particularly in the activation of type 17-associated genes (for example, Il17a, Il23r, Il1r1, Ccr6, and Gpr183; Fig. 6e ), consistent with c-Maf 's functioning upstream of Rorc. Nevertheless, Rorc(t) GFP/GFP fetal γ δ thymocytes retained some IL-17A expression ( Supplementary Fig. 6j ), as reported in ref. 13 , suggesting direct type 17 regulation by c-Maf. Indeed, both c-Maf and RORγ t showed enriched occupancy at Il17a CNS− 5 in E18 CD45RB lo γ δ thymocytes (Fig. 6f ), a region that displayed c-Maf-dependent accessibility and enhancer activity in a luciferase reporter assay in CD45RB lo Tγ δ 17 cells ( Fig. 6d and Supplementary  Fig. 6k ). Differential expression analysis also revealed c-Maf-regulated loci that were independent of RORγ t (Fig. 6e ), including Blk (ref. 29 ), Syk (ref. 34 ), and Lef1 (ref. 12 ). The conserved MARE in Blk CNS+ 39 was selectively bound by c-Maf in E18 CD45RB lo γ δ thymocytes but not in control DN3 cells (Fig. 6g) . Additionally, Blk CNS+ 39 displayed c-Maf-dependent accessibility (Fig. 6d ) and enhancer reporter activity in CD45RB lo Tγ δ 17 cells ( Supplementary  Fig. 6k ), implicating Blk as a direct c-Maf target. c-Maf also bound to a conserved MARE within the Tcf7 locus (CNS+ 16) ( Fig. 6g) . When cloned upstream of the Il17a CNS− 5 enhancer in a minimal promoter-driven luciferase construct, Tcf7 CNS+ 16 diminished the reporter activity in CD45RB lo γ δ T cells ( Supplementary Fig. 6k ), displaying silencer function. This implies that c-Maf directly attenuates Tcf7 expression. Therefore, c-Maf directed the Tγ δ 17 effector programming through RORγ t-dependent and RORγ t-independent regulation of gene expression.
TCR signal strength tunes c-Maf levels during γδ diversification.
Next we investigated signals that regulate c-Maf expression in developing fetal γ δ thymocytes. Consistent with the idea that strong TCR signals promote the differentiation of Tγ δ 1 cells over Tγ δ 17 cells 9,11 , Vγ 3 + DETCs, which depend on strong ligand-mediated TCR signals 10 , lacked high expression of c-Maf compared with Vγ 3 − γ δ thymocytes (Fig. 7a ). In addition, given the positive correlation between surface CD5 levels and TCR signal strength 35 , we observed significantly lower CD5 expression on c-Maf hi E18 γ δ thymocytes than on c-Maf lo-neg E18 γ δ thymocytes (Fig. 7b) , indicating that c-Maf expression was associated with γ δ -selection mediated by relatively weak γ δ TCR signals.
To directly investigate whether γ δ TCR signal strength regulates c-Maf expression, γ δ T cell differentiation was induced in developmentally arrested, culture-derived Rag1 −/− DN T cell precursors via transduction with distinct γ δ TCR chains derived from the KN6 (ref. 36 ), DTN40 (ref. 37 ), and C1.21 (ref. 38 ) hybridomas, which elicit strong, intermediate, and weak signals, respectively 38 . CD5 expression levels confirmed this range for γ δ TCR-transduced Rag1 −/− DN2 cells following OP9-DL1 cell culture (Fig. 7c) . Notably, we observed an inverse relationship between γ δ TCR signal strength and both the expression of c-Maf protein and the Articles NaTuRe IMMuNoLogy frequency of c-Maf + γ δ T cells (Fig. 7c ). In individual cultures of γ δ TCR-transduced cells, c-Maf hi cells were exclusive to CD5 lo populations. Moreover, stronger KN6 TCR signals enhanced the production of Tγ δ 1-associated CD45RB hi cells, whereas weaker C1.21 signals increased the generation of CD45RB lo RORγ t + Tγ δ 17 cells (Fig. 7c) . Similar results were obtained in γ δ TCRtransduced Rag1 −/− total FT DN cells differentiated in fetal thymic organ cultures ( Supplementary Fig. 7a ). While Tγ δ 17 cells derive mainly from DN2 cells 33 , Rag1 −/− DN3 cells retained the potential to generate RORγ t + γ δ T cells in culture, when provided with a weak γ δ TCR signal ( Supplementary Fig. 7b ). Thus, weak γ δ TCR signals were most permissive of high expression of c-Maf and Tγ δ 17 differentiation.
To investigate individual TCR signaling pathways in the regulation of c-Maf protein expression, culture-derived DN3 cells were transduced with constitutively active kinase mutants and differentiated in OP9-DL1 cultures. A constitutively active form of the kinase Lck (Lck F505 ), which recapitulates TCR-proximal signaling 39 , mimicked the effects of strong TCR signals (Fig. 7c ), resulting in a marked reduction in c-Maf expression and in the frequency of CD45RB lo c-Maf + RORγ t + γ δ T cells compared with the control vector ( Fig. 7d ). Lck activates downstream PKC and Ras-MAPK kinase cascades. Whereas transduction of a catalytically active PKC marginally effected γ δ T cell development (Fig. 7d) , active Ras V12 resulted in a striking enhancement in c-Maf protein and a nearly complete conversion to a CD45RB lo c-Maf + RORγ t + γ δ T cell phenotype ( Fig. 7d ). Because Ras is also activated by growth factor and cytokine receptors, the opposing effects of Lck F505 and Ras V12 suggest that strong TCR signals limit c-Maf, whereas non-TCR MAPK-independent Ras signals promote c-Maf expression. Thus, TCR signal quality and intensity permit graded levels of c-Maf protein, allowing c-Maf to function as a rheostat controlling effector γ δ T cell generation.
Discussion
Here we identified c-Maf as an essential regulator of Tγ δ 17 differentiation that was required for the induction and maintenance of RORγ t + γ δ T cells. c-Maf directly activated Rorc and key genes in the type 17 γ δ effector program (Il17a and Blk) while antagonizing genes encoding negative regulators of Tγ δ 17 differentiation. such as TCF1 (Tcf7) and Lef-1 (Lef1), that promote the alternative Tγ δ 1 fate. Globally, c-Maf was required to establish a Tγ δ 17 accessibility landscape, with particular importance at a subset of defining effector loci and enhancer elements. c-Maf expression was tuned by γ δ TCR signal strength, providing a mechanism for how weak signals are translated into Tγ δ 17 effector specialization. Taken together, our findings define c-Maf as a core node in the Tγ δ 17 network and provide novel insights into molecular mechanisms of γ δ T cell effector fate acquisition. c-Maf is selectively required for type 17 specialization in γ δ T cells. Indeed, c-Maf was not essential for Rorc expression in DP cells, innate lymphoid cells, or T H 17 cells in vivo. Although c-Maf contributes to Rorc expression in T H 17 cells, this occurs indirectly via repression of IL-2 (ref. 40 ). The distinct occupancy patterns of c-Maf in Rorc CNS in γ δ T cells compared with T H 17 cells explain the unique lineage-specific functions of c-Maf. Globally, c-Maf is an activator in Tγ δ 17 cells but is a repressor in T H 17 cells 20 . Contextdependent c-Maf activity may be governed by differences in epigenetic programming, as c-Maf contributes to the establishment of an effector-associated active regulatory landscape in Tγ δ 17 cells but not in CD4 + T cells, in which differential accessibility implicates Runx factors in chromatin remodeling 40 . Moreover, in T H 17 cells, pioneering and Rorc activation are served by the transcription factors IRF4, BATF, and STAT3 20, 41 , which are dispensable for Tγ δ 17 cells 13, 42 . Thus, c-Maf has distinct modes of gene regulation in γ δ T cells versus CD4 + helper T cells.
We defined a trajectory for Tγ δ 17 effector acquisition from post-γ δ -selected γ δ TCR int CD45RB int c-Maf lo cells to specialized mature CD45RB lo-neg CD24 − RORγ t + c-Maf hi cells. The absolute c-Maf dependence of this process uncouples effector programming from upstream γ δ -selection events, revealing a Tγ δ 17 specialization checkpoint at the immature CD45RB lo-neg CD24 + γ δ T cell stage. This is consistent with the identification of CD45RB − CD44 − γ δ fetal thymocytes as precursors of Tγ δ 17 cells 11 . The block also provides genetic support for a model in which effector programming is molecularly distinct from γ δ selection 43 . We defined a second checkpoint at the CD45RB lo RORγ t lo stage whereby survival and Tγ δ 17 identity required continued c-Maf expression. Thus, Tγ δ 17 effector commitment spans several c-Maf-dependent developmental stages. This may account for the temporal delay in the capacity for full effector cytokine expression following the expression of RORγ t in γ δ thymocytes 11 .
Discrete regulators control the specialization of distinct subsets of Tγ δ 17 cells defined by developmental stage, anatomical location, or Vγ usage 12, 15 . We identify c-Maf as a universal, non-redundant regulator of type 17 programming required for the generation and maintenance of all subsets of Tγ δ 17 cells. This implicates two tiers of regulators in specialization: TCR-independent specification factors (for example, Sox13) that perceive environmental signals to establish discrete Tγ δ 17 subsets, and commitment factors (for example, c-Maf) that impart or reinforce effector identity. Thus, c-Maf-dependence represents a unifying feature of Tγ δ 17 cell development.
c-Maf integrates various nodes in the Tγ δ 17 regulatory network. c-Maf and RORγ t collaborate in the regulation of Il17a in CD45RB lo γ δ thymocytes. c-Maf cooperates with Sox4 and Sox13 to directly activate Rorc, Blk, and Il17a expression 12 . The proximity of MARE and HMG box consensus sites in Rorc CNS+ 10 suggests physical and functional cooperativity between c-Maf and Sox factors in γ δ thymocytes, as described in other cell types 44, 45 . Such collaboration could integrate parallel regulatory pathways of discrete Tγ δ 17 subset specification by Sox and universal type 17 effector commitment by c-Maf. We that found the negative regulator TCF1 also occupied Rorc CNS+ 10. As Sox and TCF factors bind related HMG box recognition elements, c-Maf-Sox cooperativity via a composite MARE-HMG box consensus site may account for c-Maf antagonism of TCF1 occupancy. A similar lineage promotion and antagonism relationship for c-Maf and TCF1 occurs in T H 17 cells 46 , implying a conserved c-Maf-HMG box regulatory axis in type 17 specialization.
How does analog γ δ TCR stimulation translate into distinct effector fate outcomes? Differences in γ δ TCR signal strength result in graded expression of c-Maf, linking TCR signals to Tγ δ 17 effector programming. Signaling modalities compatible with the induction of c-Maf by weak γ δ TCR have been proposed 47 . γ δ TCR signals may also provide the initial licensing, via Maf accessibility or secondary targets, required for c-Maf induction by environmental signals. In this context, Notch and TGF-β are activators of c-Maf in CD4 + T cells 19, 48 . Moreover, TGF-β activates Ras signaling 49 , which potently promotes c-Maf expression in γ δ T cells. This suggests that while strong activation of the MAPK-ERK-Egr-Id3 pathway promotes the Tγ δ 1 fate 10,47 , MAPK-independent Ras signals promote c-Maf and the Tγ δ 17 fate. The finding that PI3K, a Ras target, is selectively essential for Tγ δ 17 subset differentiation 34 supports this view. Thus, c-Maf may integrate TCR and environmental inputs, permitting appropriate effector acquisition. How the resulting graded c-Maf expression is resolved into the Tγ δ 17 fate remains to be determined. In this context, a graded rheostat mechanism converts to a digital on-off switch when activators and repressors compete for the same regulatory element 50 . It is interesting to speculate that such interactions between c-Maf and TCF1, as is the case at Rorc CNS+ 10, determine γ δ T cell identity. Future work deciphering the extrinsic factors and signaling pathways that regulate c-Maf will shed light Articles NaTuRe IMMuNoLogy on the intricate process of innate-like functional programming in the thymus.
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GraphPad Prism 7 was used for statistical analysis. FlowJo ver. 9.9.4 (Tree Star) was used for analysis of flow cytometry data.
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All experiments were repeated at least 2 times, with most being repeated 3 or more times (as described in figure legends), always with similar results indicating the findings were reproducible.
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Laboratory animals
Mice were used in accordance with the Duke University Institutional Animal Care and Use Committee guidelines and housed under specific pathogen-free conditions. Mice bearing a floxed allele of Maf (Maff/f) were obtained from C. Birchmeier (Max-Delbrück Center for Molecular Medicine, Germany), and backcrossed to C57BL/6 for at least 5 generations. Il7rCre mice expressing Cre from the Il7r locus were obtained from H.R. Rodewald (German Cancer Research Center, Germany). Rorgt-Cre mice (Stock 022791, Jackson), C57Bl/6 (Taconic), Rag1-deficient (Stock 002216, Jackson), and C57BL/6 CD45.1 congenic (Stock 002014, Jackson) were bred in our facility. Timed pregnant females were generated using the Whitten effect, and CD-1 pregnant females were purchased from Charles River (Stock 022). For determination of embryonic ages, noon on the day of the post-coital plug was considered to be E0.5. Adult mice between 8 and 12 weeks of age were used in experiments.
Wild animals no wild animals
Field-collected samples no field-collected samples
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation
Isolation of hematopoietic cells from adult and fetal tissues Single cell suspensions of the thymus, spleen, and lymph nodes were obtained by mechanical disruption of the tissues through a April 2018 40μm cell strainer (Falcon). To isolate leuckocytes from the small intestine lamina propria (SILP), the small intestine was harvested, fat removed, Peyer's patches excised, and luminal contents expelled. The intestine was cut into 1-2 cm pieces and shaken in PBS containing 1mM DTT to remove mucus. The intestinal pieces were then transferred to PBS supplemented with 5mM EDTA and 10mM Hepes, and incubated twice at 37 °C for 10 min with rotation, to remove the epithelial cell layer. After the second incubation, intestinal pieces were collected and washed with digestion media (HBSS supplemented with 10% FBS and 10mM HEPES). Pieces were transferred to digestion media supplemented with collagenase D (1 mg/ml; Roche), DNaseI (0.1 mg/ ml; Sigma), and dispase (0.1 U/ml; Worthington), andsubsequently, minced with scissors and incubated in the digestion cocktail at 37 °C for 25 min with rotation. The intestinal suspension was passed through a 100 μm cell strainer and a discontinuous 40:80 Percoll gradient used to further remove epithelial cells and debris. Percoll gradient separation was performed by centrifugation at 2200 rpm for 22 min at room temperature, with no brake. SILP lymphocytes were collected at the Percoll interphase, washed, and resuspended in complete IMDM.
For cell isolation from the reproductive tract, the cervix, uterine horn, and vagina were combined and processed similar to the SILP, except that the digestion time was extended to 60 minutes. For mouse fetal tissues, E15-18 fetal thymii and E14-15 fetal liver (FL) were harvested and single-cell suspensions were generated by disruption through a 40 m nylon mesh using a syringe plunger. CD24low/-FL hematopoietic progenitor cells (HPC) were enriched by antibody-and complement-mediated lysis. Here, cell suspensions from up to 30 FL were incubated in a total of 10 mL of complete medium containing 2.5 g/mL of purified anti-CD24 (J11d, BD Biosciences) and a 1:10 dilution of Low-tox rabbit complement (Cedarlane) for 30 min at 37°C. Viable HPC were recovered by density gradient centrifugation over Lympholyte-M (Cedarlane), and washed once in complete medium prior to culture.
Flow Cytometry. Single cell suspensions were surface stained with flourochrome-conjugated antibodies in PBS containing 0.5% BSA and 2mM EDTA (staining buffer) for 30 min at 4 °C. Primary cells were blocked with anti-FcγR (93; Biolegend), prior to staining surface markers. To allow for the exclusion of dead cells in all analyses, a fixable viability dye (eBioscience) was included with the surface staining. For live cell flow cytometric analysis or cell sorting, cells were washed twice and resuspended in staining buffer. For intracellular staining, cells were washed twice with staining buffer and resuspended in Fixation-Permeabilization solution (Foxp3/ Transcription Factor Staining Buffer Set; eBioscience; 00-5523-00), with subsequent intracellular staining performed as detailed in the protocol provided with the kit. AnnexinV staining (Annexin V Apoptosis Detection Kit; eBioscience; 88-8006-74) was performed prior to fixation and in accordance with the manufacturer's protocol provided. Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
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